Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
S-64315 by Les Laboratoires Servier for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
S-64315 is under clinical development by Les Laboratoires Servier and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute...
Data Insights
S-64315 by Les Laboratoires Servier for Myelodysplastic Syndrome: Likelihood of Approval
S-64315 is under clinical development by Les Laboratoires Servier and currently in Phase I for Myelodysplastic Syndrome. According to GlobalData,...